“Inhibition of IRAK 1 4 Alleviates Colitis by Inhibiting TLR4 NF-κB Pathway and Protecting the Intestinal Barrier”. 2022. Biomolecules and Biomedicine 22 (6): 872-81. https://doi.org/10.17305/bjbms.2022.7348.